110 related articles for article (PubMed ID: 26617911)
1. Primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck rarely involving epiglottis: clinicopathological, immunohistomchemical and genetic features of a case.
Zhou J; Wang G; Zhang D; Yin Y; Pang X; Zhang J; Zhang Y; Li W
Int J Clin Exp Pathol; 2015; 8(9):11685-90. PubMed ID: 26617911
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck.
Wang W; Cai Y; Sheng W; Lu H; Li X
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jan; 117(1):96-104. PubMed ID: 24332333
[TBL] [Abstract][Full Text] [Related]
3. Mucosal CD30-Positive T-Cell Lymphoproliferative Disorder Arising in the Oral Cavity Following Dental Implants: Report of the First Case.
Yoon HJ; Choe JY; Jeon YK
Int J Surg Pathol; 2015 Dec; 23(8):656-61. PubMed ID: 26261101
[TBL] [Abstract][Full Text] [Related]
4. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
Wang X; Ng CS; Chen C; Yu G; Yin W
Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features of primary mucosal CD30-positive T-cell lymphoproliferative disorders in head and neck region].
Liu F; Li M; Zhang LY; Guo L; Hu WW; Rao HL
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):412-416. PubMed ID: 29886583
[No Abstract] [Full Text] [Related]
6. Primary hepatic Epstein-Barr virus-associated CD30-positive peripheral T-cell lymphoma of cytotoxic phenotype.
Peng Y; Cai J; Yue C; Qing X
Exp Mol Pathol; 2016 Feb; 100(1):207-11. PubMed ID: 26778690
[TBL] [Abstract][Full Text] [Related]
7. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa--an indolent lesion: report of 4 cases.
Agarwal M; Shenjere P; Blewitt RW; Hall G; Sloan P; Pigadas N; Banerjee SS
Int J Surg Pathol; 2008 Jul; 16(3):286-90. PubMed ID: 18387994
[TBL] [Abstract][Full Text] [Related]
8. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder.
Magro C; Crowson AN; Kovatich A; Burns F
Hum Pathol; 2002 Aug; 33(8):788-95. PubMed ID: 12203210
[TBL] [Abstract][Full Text] [Related]
9. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
Martires KJ; Ra S; Abdulla F; Cassarino DS
Am J Dermatopathol; 2015 Nov; 37(11):822-33. PubMed ID: 26485239
[TBL] [Abstract][Full Text] [Related]
10. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
Plaza JA; Feldman AL; Magro C
J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
[TBL] [Abstract][Full Text] [Related]
12. Self-regressing oral CD30-positive, EBV-negative, T-cell lymphoproliferative lesions. A poorly understood process highlighted by ominous clinicopathologic features and indolent behavior.
Argyris PP; Ho D; Islam MN; Khurram SA; Courville EL; Morgan S; Sundick B; Soliman M; Janakiram M; Gopalakrishnan R; Koutlas IG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Dec; 132(6):698-707. PubMed ID: 34526251
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages.
De Souza A; Tinguely M; Burghart DR; Berisha A; Mertz KD; Kempf W
J Cutan Pathol; 2016 Jul; 43(7):579-88. PubMed ID: 27080437
[TBL] [Abstract][Full Text] [Related]
14. FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.
Gjerdrum LM; Woetmann A; Odum N; Hother C; Henrik-Nielsen R; Gniadecki R; Ralfkiaer E
Eur J Haematol; 2008 Jun; 80(6):483-9. PubMed ID: 18331599
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil-rich CD30+ lymphoproliferative disorder of the oral mucosa. A form of "traumatic eosinophilic granuloma".
Alobeid B; Pan LX; Milligan L; Budel L; Frizzera G
Am J Clin Pathol; 2004 Jan; 121(1):43-50. PubMed ID: 14750239
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification.
Kempf W; Kazakov DV; Cozzio A; Kamarashev J; Kerl K; Plaza T; Metze D
Am J Dermatopathol; 2013 Apr; 35(2):159-66. PubMed ID: 22885550
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological characteristics of natural killer cell enteropathy: report of two cases and review of literature].
Huo YJ; Zhang DD; Zhou L; Li CF; Wang GN; Zhao WG; Zhang YP; Jian XY; Huang HF; Li WC
Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):108-113. PubMed ID: 35152628
[No Abstract] [Full Text] [Related]
18. Oral eosinophilic ulcer, an Epstein-Barr virus-associated CD30+ lymphoproliferation?
Abdel-Naser MB; Tsatsou F; Hippe S; Knolle J; Anagnostopoulos I; Stein H; Zouboulis CC
Dermatology; 2011; 222(2):113-8. PubMed ID: 21464557
[TBL] [Abstract][Full Text] [Related]
19. CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes.
Guitart J; Martinez-Escala ME; Deonizio JM; Gerami P; Kadin ME
J Am Acad Dermatol; 2015 Mar; 72(3):508-15. PubMed ID: 25582534
[TBL] [Abstract][Full Text] [Related]
20. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
